Health and Fitness Health and Fitness
Fri, November 5, 2010

Alkermesa? Corporate Presentation to be Webcast at the Credit Suisse Healthcare Conference


Published on 2010-11-05 06:07:03 - Market Wire
  Print publication without navigation


WALTHAM, Mass.--([ BUSINESS WIRE ])--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Credit Suisse Healthcare Conference on Thursday, November 11, 2010, at 11:00 a.m. MT (1:00 p.m. ET) from the Arizona Biltmore in Phoenix, Arizona. The presentation may be accessed under the investor relations tab at [ www.alkermes.com ]. The presentation will be archived for 14 days.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol and opioid dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.

Contributing Sources